<DOC>
	<DOCNO>NCT01511575</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood , tissue , bone marrow patient cancer laboratory may help doctor learn change occur RNA identify biomarkers related cancer . PURPOSE : This research trial study RNA sample patient Down syndrome acute myeloid leukemia transient myeloproliferative disorder .</brief_summary>
	<brief_title>Studying Biomarker Expression Samples From Patients With Down Syndrome Acute Myeloid Leukemia Other Transient Myeloproliferative Disorder</brief_title>
	<detailed_description>OBJECTIVES : - To compare miRNA expression distinctive diagnostic group : transient myeloproliferative disorder ( TMD ) , Down syndrome ( DS ) acute megakaryocytic leukemia ( AMkL ) , non-DS AMkL , remission DS sample ( represent germline , non-malignant sample ) . OUTLINE : Archived RNA sample analyze mature micro ( mi ) RNA expression real-time RT-PCR . Results compare miRNA expression non-Down syndrome patient acute megakaryocytic leukemia .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Down Syndrome</mesh_term>
	<mesh_term>Myeloproliferative Disorders</mesh_term>
	<mesh_term>Leukemoid Reaction</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients Down syndrome ( DS ) diagnose acute myeloid leukemia transient myeloproliferative disorder Clinical sample obtain patient enrolled COG AAML0431 COG AAML08B1 PATIENT CHARACTERISTICS : Previously consent biologic study PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Years</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>childhood acute myeloid leukemia remission</keyword>
	<keyword>childhood acute myeloid leukemia/other myeloid malignancy</keyword>
	<keyword>childhood acute megakaryocytic leukemia ( M7 )</keyword>
</DOC>